Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis-Reference-Cited by-同舟云学术

Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis

Published:2017-07 Issue:7 Volume:5 Page:524-533
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Saleheen Danish,Haycock Philip C,Zhao Wei,Rasheed Asif,Taleb Adam,Imran Atif,Abbas Shahid,Majeed Faisal,Akhtar Saba,Qamar Nadeem,Zaman Khan Shah,Yaqoob Zia,Saghir Tahir,Rizvi Syed Nadeem Hasan,Memon Anis,Mallick Nadeem Hayyat,Ishaq Mohammad,Rasheed Syed Zahed,Memon Fazal-ur-Rehman,Mahmood Khalid,Ahmed Naveeduddin,Frossard Philippe,Tsimikas Sotirios,Witztum Joseph L,Marcovina Santica,Sandhu Manjinder,Rader Daniel J,Danesh John

Funder

British Heart Foundation

US National Institutes of Health

Fogarty International Center

the Wellcome Trust

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference30 articles.

1. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality;JAMA,2009

2. Genetic variants associated with Lp(a) lipoprotein level and coronary disease;Clarke;N Engl J Med,2009